mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |